Barequet Irina S, Habot-Wilner Zohar, Keller Nathan, Smollan Gill, Ziv Hana, Belkin Michael, Rosner Mordechai
Goldschleger Eye Institute, Sheba Medical Center, 52621 Tel-Hashomer, Israel.
Invest Ophthalmol Vis Sci. 2008 Jan;49(1):163-7. doi: 10.1167/iovs.07-1005.
To study, with the use of an animal model, the efficacy of amniotic membrane (AM) transplantation as adjunctive treatment in corneal healing after bacterial keratitis.
Staphylococcus aureus keratitis was induced in 47 rats by injection of bacteria into the corneal stroma. Treatment was started 48 hours later with one of three randomly assigned protocols: cefazolin drops (50 mg/mL) and AM transplantation (n = 16); nonpreserved 0.9% saline drops and AM transplantation (n = 15); or cefazolin without AM transplantation (n = 16). Cefazolin and saline drops were administered every 30 minutes for 6 hours, then hourly for 6 hours. AM was transplanted 24 hours after termination of cefazolin or saline treatment. Results were clinically assessed 7 days after AM transplantation or at the corresponding time in the nontransplanted animals. The rats were then killed, and their corneas were removed for bacterial counts or histopathologic examination.
The best clinical results were observed in the group treated with cefazolin and AM transplantation, manifested by the least corneal haze and neovascularization (P = 0.007 and P = 0.014, respectively) and minimal bacterial counts (28 colony-forming units [CFU]/mL compared with 160 CFU/mL and 240 CFU/mL, respectively). Histopathologic examination showed that the central corneal vessels from rats treated with cefazolin and AM were smaller and less congested than those from the other two groups.
AM transplantation is a useful adjunctive treatment after bacterial keratitis in this rat model. The transplanted AM improved the healing process, resulting in decreased corneal haze and less neovascularization.
利用动物模型研究羊膜(AM)移植作为细菌性角膜炎后角膜愈合辅助治疗的疗效。
通过向47只大鼠角膜基质内注射细菌诱导金黄色葡萄球菌角膜炎。48小时后开始治疗,采用三种随机分配方案之一:头孢唑啉滴眼液(50mg/mL)和AM移植(n = 16);非保存的0.9%盐水滴眼液和AM移植(n = 15);或头孢唑啉但不进行AM移植(n = 16)。头孢唑啉和盐水滴眼液每30分钟给药一次,共6小时,然后每小时给药一次,共6小时。在头孢唑啉或盐水治疗结束24小时后进行AM移植。在AM移植7天后或在未移植动物的相应时间进行临床评估。然后处死大鼠,取出角膜进行细菌计数或组织病理学检查。
在接受头孢唑啉和AM移植治疗的组中观察到最佳临床结果,表现为角膜混浊和新生血管形成最少(分别为P = 0.007和P = 0.014),细菌计数最低(分别为28个菌落形成单位[CFU]/mL,而其他两组分别为160 CFU/mL和240 CFU/mL)。组织病理学检查显示,接受头孢唑啉和AM治疗的大鼠角膜中央血管比其他两组的更小且充血更少。
在该大鼠模型中,AM移植是细菌性角膜炎后的一种有效辅助治疗方法。移植的AM改善了愈合过程,导致角膜混浊减轻和新生血管形成减少。